Retrospective analysis of histopathologic prognostic factors after hepatectomy for intrahepatic cholangiocarcinoma

Cancer Journal

Volumn 15, Issue 3, 2009, Pages 257-261

  Jiang, Bei Ge ^a   Sun, Liang Liang ^b   Yu, Wen Long ^a   Tang, Zhao Hui ^a   Zong, Ming ^a   Zhang, Yong Jie ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Histopathology; Intrahepatic cholangiocarcinoma; Prognosis; Resection

Indexed keywords

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; UNIVARIATE ANALYSIS; BILE DUCT TUMOR; INTRAHEPATIC BILE DUCT; LIVER TUMOR; MIDDLE AGED; MORTALITY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; LAPAROTOMY; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 67651177513     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e31819e3312     Document Type: Article

References (24)

1. de Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. N Engl J Med. 1999;341:1368-1378.
2. Shaib Y, Ei-serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115-125.
3. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10-14. (Pubitemid 38851311)
4. Khan SA, Taylor-Robinson SD, Tolendano MB, et al. Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol. 2002;37:806-813.
5. Ohtsuka M, Ito H, Kimura F, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89:1525-1531. (Pubitemid 35404319)
6. Lang H, Sotiropoulos GC, Frühauf NR, et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC). Ann Surg. 2005;241: 134-143.
7. Nakagohri T, Asano T, Kinoshita H, et al. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg. 2003;27:289-293. (Pubitemid 36920139)
8. Suzuki S, Sakaguchi T, Yokoi Y, et al. Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg. 2002;26:687-693. (Pubitemid 36920344)
9. Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg. 2001;193:384-391. (Pubitemid 32895979)
10. Kawarada Y, Yamagiwa K, Das BC. Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg. 2002;183:679-685. (Pubitemid 34722537)
11. Uenishi T, Hirohashi K, Kubo S, et al. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma. Hepatogastroenterology. 2003;50:1069-1072. (Pubitemid 36723845)
12. Shimada M, Yamashita Y, Aishima S, et al. Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg. 2001;88:1463-1466. (Pubitemid 32989464)
13. Isaji S, Kawarada Y, Taoka H, et al. Clinicopathologic features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg. 1999;6:108-116.
14. Paik KY, Jung JC, Heo JS, et al. What prognostic factors are important for resected intrahepatic sholangiocarcinoma? J Gastroenterol Hepatol. 2008;23:766-770.
15. Nakagawa T, Kamiyama T, Kurauchi N, et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg. 2005;29:728-733. (Pubitemid 41187533)
16. Inoue K, Makuuchi M, Takayama T, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery. 2000;127:498-505. (Pubitemid 30257507)
17. Akatsu T, Shimazu M, Kawachi S, et al. Long-term survival of intrahepatic cholangiocarcinoma with hilar lymph node metastasis and portal vein involvement. Hepatogastroenterology. 2005;52:603-605. (Pubitemid 40469476)
18. Asakura H, Ohtsuka M, Ito H, et al. Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph node metastasis. Hepatogastroenterology. 2005;52:722-724. (Pubitemid 40834591)
19. Yamamoto M, Takasaki K, Imaizumi T, et al. A long-term survivor of intrahepatic cholangiocarcinoma with lymph node metastasis: a case report. Jpn J Clin Oncol. 2002;32:206-209. (Pubitemid 41288998)
20. Uenishi T, Yamazaki O, Horii K, et al. A long-term survivor of intrahepatic cholangiocarcinoma with paraaortic lymph node metastasis. J Gastroenterol. 2006;41:391-392. (Pubitemid 43834386)
21. Okami J, Dohno K, Sakon M, et al. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma. Clin Cancer Res. 2000;6:2326-2332. (Pubitemid 30399199)
22. Meyer CG, Penn I, James L. Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation. 2000;69:1633-1637. (Pubitemid 30845611)
23. Goldstein RM, Stone M, Tillery GW, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg. 1993;166:768-771. (Pubitemid 24309361)
24. Pichlmayr R, Lamesch P, Weimann A, et al. Surgical treatment of cholangiocellular carcinoma. World J Surg. 1995;19:83-88.